• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植后中心性浆液性脉络膜视网膜病变。

Central serous chorioretinopathy after renal transplantation.

机构信息

Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Retina. 2011 Oct;31(9):1896-903. doi: 10.1097/IAE.0b013e31820a69ee.

DOI:10.1097/IAE.0b013e31820a69ee
PMID:21499191
Abstract

PURPOSE

To describe the demographic and clinical characteristics of central serous chorioretinopathy (CSC) after renal transplantation (RT).

METHODS

A retrospective medical chart review was performed on 451 among 2,980 patients, who underwent RT and visited vitreoretinal clinic at Yonsei Medical Center from 1979 to 2009. Correlation between daily corticosteroid dosage and remission time and factors relating to final visual acuity of <20/40 were studied.

RESULTS

Twenty-eight patients (39 eyes) developed CSC at a median of 63 months after RT (range, 2 months to 20 years), and 18 (64%) patients were men. Accordingly, the prevalence of CSC after RT was estimated to be between 1% and 6%. All patients received a combination of corticosteroid and at least one other immunosuppressant agent at presentation. Reducing the daily corticosteroid dosage by 25% to 50% in CSC with classic pattern resulted in twice as faster remission (2 months) compared with the maintained dosage group (P = 0.025). Central serous chorioretinopathy recurrence (P = 0.002), intrinsic renal disease as cause of RT (P = 0.003), severe CSC variant (P = 0.009), and presenting visual acuity <20/40 (P = 0.009) predicted a final visual acuity <20/40.

CONCLUSION

Central serous chorioretinopathy develops relatively often after RT and varies in presentation and severity. The cause of CSC after RT appears to be multifactorial and closely related to corticosteroid.

摘要

目的

描述肾移植(RT)后中心性浆液性脉络膜视网膜病变(CSC)的人口统计学和临床特征。

方法

对 1979 年至 2009 年间在延世医疗中心接受 RT 并接受玻璃体视网膜门诊治疗的 2980 名患者中的 451 名进行了回顾性病历审查。研究了每日皮质类固醇剂量与缓解时间之间的相关性,以及与最终视力<20/40 相关的因素。

结果

28 例(39 只眼)在 RT 后中位数为 63 个月(范围 2 个月至 20 年)时发生 CSC,18 例(64%)为男性。因此,RT 后 CSC 的患病率估计在 1%至 6%之间。所有患者在就诊时均接受皮质类固醇和至少一种其他免疫抑制剂的联合治疗。与维持剂量组相比,具有经典模式的 CSC 中,将每日皮质类固醇剂量减少 25%至 50%可使缓解时间快一倍(P=0.025)。CSC 复发(P=0.002)、RT 的固有肾脏疾病原因(P=0.003)、严重 CSC 变异(P=0.009)和就诊时视力<20/40(P=0.009)预测最终视力<20/40。

结论

CSC 在 RT 后相对常见,其表现和严重程度不同。RT 后 CSC 的病因似乎是多因素的,与皮质类固醇密切相关。

相似文献

1
Central serous chorioretinopathy after renal transplantation.肾移植后中心性浆液性脉络膜视网膜病变。
Retina. 2011 Oct;31(9):1896-903. doi: 10.1097/IAE.0b013e31820a69ee.
2
Central serous chorioretinopathy after solid organ transplantation.实体器官移植后发生的中心性浆液性脉络膜视网膜病变
Ophthalmology. 2006 May;113(5):805-13.e5. doi: 10.1016/j.ophtha.2006.01.031.
3
Seventeen cases of central serous chorioretinopathy associated with systemic corticosteroid therapy.
Ophthalmologica. 2004 Mar-Apr;218(2):107-10. doi: 10.1159/000076145.
4
Changes in choroidal thickness after systemic administration of high-dose corticosteroids: a pilot study.全身大剂量应用皮质类固醇后脉络膜厚度的变化:一项初步研究。
Invest Ophthalmol Vis Sci. 2014 Jan 21;55(1):440-5. doi: 10.1167/iovs.13-12854.
5
Risk factors for recurrence of serous macular detachment in untreated patients with central serous chorioretinopathy.未经治疗的中心性浆液性脉络膜视网膜病变患者发生浆液性黄斑脱离复发的危险因素。
Ophthalmic Res. 2011;46(3):160-3. doi: 10.1159/000324599. Epub 2011 Mar 10.
6
The natural history of pigment epithelial detachment associated with central serous chorioretinopathy.与中心性浆液性脉络膜视网膜病变相关的色素上皮脱离的自然病程。
Retina. 2007 Nov-Dec;27(9):1168-73. doi: 10.1097/IAE.0b013e318156db8a.
7
Atypical severe central serous chorioretinopathy in a patient with systemic lupus erythematosus improved with a rapid reduction in glucocorticoid.系统性红斑狼疮患者伴发典型非严重中心性浆液性脉络膜视网膜病变,经糖皮质激素快速减量后改善。
Mod Rheumatol. 2013 Jan;23(1):172-4. doi: 10.1007/s10165-012-0629-6. Epub 2012 Mar 25.
8
Fundus autofluorescence and visual acuity in central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变的眼底自发荧光和视力。
Ophthalmology. 2011 Apr;118(4):700-5. doi: 10.1016/j.ophtha.2010.08.017. Epub 2010 Nov 5.
9
High-resolution imaging of resolved central serous chorioretinopathy using adaptive optics scanning laser ophthalmoscopy.应用自适应光学扫描激光检眼镜对已解决的中心性浆液性脉络膜视网膜病变进行高分辨率成像。
Ophthalmology. 2010 Sep;117(9):1800-9, 1809.e1-2. doi: 10.1016/j.ophtha.2010.01.042. Epub 2010 Jul 29.
10
Clinical factors related to visual outcome in central serous chorioretinopathy.与中心性浆液性脉络膜视网膜病变的视觉预后相关的临床因素。
Retina. 2010 Jul-Aug;30(7):1128-34. doi: 10.1097/IAE.0b013e3181cdf381.

引用本文的文献

1
Efficacy of dexamethasone implant in the management of chronic central serous chorioretinopathy without choroidal neovascularization.地塞米松植入物治疗无脉络膜新生血管的慢性中心性浆液性脉络膜视网膜病变的疗效
Indian J Ophthalmol. 2025 Jan 1;73(Suppl 1):S100-S106. doi: 10.4103/IJO.IJO_626_24. Epub 2024 Jul 11.
2
Central serous chorioretinopathy: Pathophysiology, systemic associations, and a novel etiological classification.中心性浆液性脉络膜视网膜病变:病理生理学、全身关联及一种新的病因分类
Taiwan J Ophthalmol. 2022 Dec 5;12(4):381-393. doi: 10.4103/2211-5056.362601. eCollection 2022 Oct-Dec.
3
Bilateral Multiple Serous Retinal Detachments Following Bone Marrow Transplantation.
骨髓移植后双侧多发性浆液性视网膜脱离
J Ophthalmic Vis Res. 2019 Apr-Jun;14(2):219-222. doi: 10.4103/jovr.jovr_139_17.
4
Spectrum of retinal abnormalities in renal transplant patients using chronic low-dose steroids.使用慢性低剂量类固醇的肾移植患者的视网膜异常谱
Graefes Arch Clin Exp Ophthalmol. 2017 Dec;255(12):2443-2449. doi: 10.1007/s00417-017-3823-6. Epub 2017 Oct 23.
5
Comparison of Serum Cortisol and Testosterone Levels in Acute and Chronic Central Serous Chorioretinopathy.急性和慢性中心性浆液性脉络膜视网膜病变患者血清皮质醇和睾酮水平的比较
Korean J Ophthalmol. 2015 Dec;29(6):382-8. doi: 10.3341/kjo.2015.29.6.382. Epub 2015 Nov 25.
6
Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients.中心性浆液性脉络膜视网膜病变患者玻璃体内注射贝伐单抗治疗有效者的临床特征
Eye (Lond). 2015 Jun;29(6):732-40; quiz 741. doi: 10.1038/eye.2015.58. Epub 2015 May 8.
7
Idiopathic organ transplant chorioretinopathy after liver transplantation.肝移植后特发性器官移植性脉络膜视网膜病变
Case Rep Ophthalmol Med. 2015;2015:964603. doi: 10.1155/2015/964603. Epub 2015 Mar 16.